These results indicate that MMP-7 and MMP-10 not only differentiate cervical cancer from dysplasia and healthy controls but also reflect disease stage, supporting their potential clinical application as sensitive and specific serum biomarkers. This evidence concerns the gene MMP10 and cervical carcinoma.